{"id":"https://openalex.org/W4397044270","doi":"https://doi.org/10.1681/asn.20233411s1856d","title":"Comparative Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus","display_name":"Comparative Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4397044270","doi":"https://doi.org/10.1681/asn.20233411s1856d"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20233411s1856d","doi":"https://doi.org/10.1681/asn.20233411s1856d","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1856d","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009676752","display_name":"Daniel L. Edmonston","orcid":"https://orcid.org/0000-0003-2589-6993","observed_orcids":["https://orcid.org/0000-0003-2589-6993"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Edmonston","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;","Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009790128","display_name":"Hillary S. Mulder","orcid":"https://orcid.org/0000-0003-4838-582X","observed_orcids":["https://orcid.org/0000-0003-4838-582X"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hillary Mulder","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062894269","display_name":"Elizabeth J. Lydon","orcid":"https://orcid.org/0009-0005-9487-8598","observed_orcids":["https://orcid.org/0009-0005-9487-8598"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Lydon","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002193815","display_name":"Karen Chiswell","orcid":"https://orcid.org/0000-0002-0279-9093","observed_orcids":["https://orcid.org/0000-0002-0279-9093"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Chiswell","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000029652","display_name":"Zachary M. Lampron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Lampron","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013041140","display_name":"Christina M. Shay","orcid":"https://orcid.org/0000-0002-8310-7043","observed_orcids":["https://orcid.org/0000-0002-8310-7043"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christina M. Shay","raw_affiliation_strings":["Boehringer Ingelheim International GmbH, Ingelheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim International GmbH, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021627780","display_name":"Keith A. Marsolo","orcid":"https://orcid.org/0000-0002-4416-1549","observed_orcids":["https://orcid.org/0000-0002-4416-1549"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith A. Marsolo","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023880478","display_name":"Hayden Barry Bosworth","orcid":"https://orcid.org/0000-0001-6188-9825","observed_orcids":["https://orcid.org/0000-0001-6188-9825"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hayden Bosworth","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;","Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088989269","display_name":"Neha Jadeja Pagidipati","orcid":"https://orcid.org/0000-0002-5004-8868","observed_orcids":["https://orcid.org/0000-0002-5004-8868"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neha Pagidipati","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC;","Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC;","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2056,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.60906321,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"34","issue":"11S","first_page":"856","last_page":"857"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9860000014305115},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/renal-outcomes","display_name":"renal outcomes","score":0.5270000100135803},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.9890000224113464},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.796999990940094},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9769999980926514},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9890000224113464},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.9599999785423279},{"id":"https://openalex.org/keywords/genital-mycotic-infections","display_name":"genital mycotic infections","score":0.9200000166893005},{"id":"https://openalex.org/keywords/diabetic-ketoacidosis","display_name":"diabetic ketoacidosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6510000228881836},{"id":"https://openalex.org/keywords/comparative-drug-safety","display_name":"drug safety comparison","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9544059038162231},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8148396015167236},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.6311452388763428},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5985984206199646},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5246886610984802},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.48506656289100647},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.471609890460968},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3929140269756317},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36298203468322754},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.34678906202316284}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20233411s1856d","doi":"https://doi.org/10.1681/asn.20233411s1856d","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1856d","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394893848","https://openalex.org/W4281698398","https://openalex.org/W4306630441","https://openalex.org/W4313531576","https://openalex.org/W2756191633","https://openalex.org/W4400059283","https://openalex.org/W4386347011","https://openalex.org/W4382502506","https://openalex.org/W4396989930","https://openalex.org/W3210055886"],"abstract_inverted_index":{"Background:":[0],"Placebo-controlled":[1],"trials":[2],"of":[3,36,75,97,139,154,264],"sodium-glucose":[4],"cotransporter-2":[5],"inhibitors":[6,41],"(SGLT2i)":[7],"demonstrated":[8],"kidney":[9,23,242,258,277],"and":[10,21,34,48,114,124,150,168,190,213,231,243,255,259,262,274],"cardiovascular":[11,113,152,244,260],"benefit":[12],"for":[13,148,207,241],"people":[14],"with":[15,45,47,81,136,171,221,228,230,237,247,271,273],"type":[16],"2":[17,108],"diabetes":[18],"mellitus":[19],"(T2DM)":[20],"chronic":[22,276],"disease":[24],"(CKD).":[25],"We":[26,52,110],"used":[27,53],"real-world":[28,226],"data":[29,57],"to":[30,38,144,267],"compare":[31],"the":[32,73,140,194],"effectiveness":[33,74,261],"safety":[35,115,196,263],"empagliflozin":[37,76,123,166,234,265],"dipeptidyl":[39],"peptidase-4":[40],"(DPP4i)":[42],"in":[43,65,79,163,169,175,200,205,219,269],"patients":[44,80,164,201,220,270],"T2DM,":[46],"without":[49,232,275],"CKD.":[50,172,222],"Methods:":[51],"electronic":[54],"health":[55,62],"record":[56],"from":[58],"20":[59],"large":[60],"US":[61],"systems":[63],"participating":[64],"PCORnet\u00a9.":[66],"Using":[67],"propensity":[68],"overlap":[69],"weighting,":[70],"we":[71],"compared":[72,143,246,266],"vs.":[77],"DPP4i":[78,145,268],"T2DM":[82,229,272],"among":[83],"those":[84,170],"newly":[85],"prescribed":[86,165,202],"these":[87],"medications":[88],"between":[89,180],"2016-2020.":[90],"Primary":[91],"composite":[92,153],"endpoint":[93],"included":[94],"first":[95],"occurrence":[96],"40%":[98,210],"eGFR":[99,211],"decline,":[100],"incident":[101],"ESKD,":[102],"or":[103,158],"all-cause":[104],"mortality":[105],"(ACM)":[106],"through":[107],"years.":[109,132],"also":[111,161,216],"assessed":[112],"outcomes.":[116],"Results:":[117],"Among":[118],"62,197":[119],"patients,":[120],"32%":[121],"initiated":[122,126],"68%":[125],"DPP4i.":[127,248],"Median":[128],"follow-up":[129],"was":[130,134],"1.1":[131],"Empagliflozin":[133],"associated":[135,236],"lower":[137,162,218,239],"risk":[138,179,206,240],"primary":[141,208],"outcome":[142],"(Table).":[146],"Risk":[147],"ACM":[149,159,214],"a":[151,225],"stroke,":[155],"myocardial":[156],"infarction,":[157],"were":[160,193,215],"overall":[167],"The":[173],"difference":[174],"heart":[176],"failure":[177],"hospitalization":[178],"groups":[181],"did":[182],"not":[183],"reach":[184],"statistical":[185],"significance.":[186],"Genital":[187],"mycotic":[188],"infections":[189],"diabetic":[191],"ketoacidosis":[192],"only":[195],"events":[197],"more":[198],"common":[199],"empagliflozin.":[203],"Differences":[204],"composite,":[209],"decline":[212],"significantly":[217,238],"Conclusions:":[223],"In":[224],"population":[227],"CKD,":[233],"is":[235],"outcomes":[245],"Funding:":[249],"Commercial":[250],"Support":[251],"-":[252],"Boehringer":[253],"Ingelheim":[254],"LillyTable.:":[256],"Comparative":[257],"disease:":[278],"PCORnet\u00a9":[279]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2024-05-19T00:00:00"}